| Data | Hora | Fonte | Título | Código | Companhia |
| 14/02/2014 | 18:15 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 10/10/2013 | 16:54 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 23/09/2013 | 10:35 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 17/09/2013 | 07:00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 19:25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 17:03 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 17:03 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 17:02 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 18:11 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 18:10 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 18:08 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 17:30 | Business Wire | Cubist Pharmaceuticals Completes Acquisition of Trius Therapeutics | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 17:26 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 12:00 | Business Wire | Cubist Pharmaceuticals Announces Results of Tender Offer for Outstanding Shares of Trius Therapeutics | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 06/09/2013 | 17:01 | GlobeNewswire Inc. | Trius Therapeutics to Present Data From Antibiotics Development Programs at ICAAC 2013 | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 29/08/2013 | 17:00 | Business Wire | Cubist Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of Trius | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/08/2013 | 11:18 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/08/2013 | 11:08 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 07/08/2013 | 17:47 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 06/08/2013 | 17:00 | GlobeNewswire Inc. | Trius Therapeutics Reports Second Quarter 2013 Financial Results | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 06/08/2013 | 13:44 | PR Newswire (US) | SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Trius Therapeutics, Inc. - TSRX | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 05/08/2013 | 09:00 | PR Newswire (US) | Strategic Initiatives, Executive Transitions, and Strengthened Portfolios to Increase Shareholder Value - Research Report on ... | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 02/08/2013 | 12:14 | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 01/08/2013 | 16:12 | Business Wire | Investigations into Proposed Buyouts of Optimer Pharmaceuticals, Inc., Trius Therapeutics, Inc. & Maidenform Brands, Inc. Ann... | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 01/08/2013 | 12:20 | Business Wire | TRIUS THERAPEUTICS SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Trius The... | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 01/08/2013 | 11:53 | PR Newswire (US) | Ryan & Maniskas, LLP Announces Investigation of Trius Therapeutics, Inc. | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 01/08/2013 | 09:00 | Business Wire | Faruqi & Faruqi, LLP, Partner Juan E. Monteverde Launches an Investigation of Trius Therapeutics, Inc. Over the Proposed Sale... | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 31/07/2013 | 22:54 | Business Wire | TRIUS THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Trius Ther... | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 31/07/2013 | 16:16 | PR Newswire (US) | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Trius Therapeutics, Inc. - TSRX | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 31/07/2013 | 14:48 | Business Wire | Rigrodsky & Long, P.A. Announces Investigation Of Trius Therapeutics, Inc. Buyout | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |